Innate Pharma SA Defined Benefit Obligation At Present Value
Innate Pharma SA (IPHYF) had Defined Benefit Obligation At Present Value of EUR 1.92 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:DefinedBenefitObligationAtPresentValue · last filed 2026-04-01
- 2025-12-31: Defined Benefit Obligation At Present Value 1.92M EUR.
- 2025-06-30: Defined Benefit Obligation At Present Value 2.67M EUR.
- 2024-12-31: Defined Benefit Obligation At Present Value 2.73M EUR.
- 2024-06-30: Defined Benefit Obligation At Present Value 2.47M EUR.
| Period end | Defined Benefit Obligation At Present Value |
|---|---|
| 2025-12-31 | 1.92M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 2.67M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 2.73M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 2.47M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 2.44M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 2.53M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 2.55M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 2.70M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 2.98M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 3.88M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 4.18M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 3.76M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 3.70M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 2.62M EUR 20-F · filed 2020-04-24 |